Full-Time
Equity crowdfunding platform for investors
No salary listed
Mid, Senior
Austin, TX, USA
Get referrals →
You have ways to get a MicroVentures referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 4 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
MicroVentures operates an equity crowdfunding platform that allows both accredited and non-accredited investors to invest in high-growth startups and private market opportunities. The platform simplifies the investment process by providing access to early-stage investment opportunities that were once limited to venture capitalists and institutional investors. MicroVentures generates revenue through a dual-fee structure, where investors pay a fee based on their investment amount, and companies pay a fee to list their fundraising campaigns. Additionally, the company offers educational resources to help investors understand the risks and make informed decisions about equity crowdfunding. This focus on accessibility and education sets MicroVentures apart from its competitors in the fintech market.
Company Size
51-200
Company Stage
N/A
Total Funding
$3.2M
Headquarters
Austin, Texas
Founded
2009
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
401(k) Retirement Plan
401(k) Company Match
Company Equity
Performance Bonus
Oakland-based Mighty Buildings, which is on a quest to build homes using 3D printing, robotics and automation, has raised a $22 million extension to its Series B round of funding. The company claims to be able to 3D print structures “two times as quickly with 95% less labor hours and 10-times less waste” than conventional construction. For example, it says it can 3D print a 350-square-foot studio apartment in just 24 hours.
3D Printed Biodegradable Mesh Designed to Deliver Cancer Drugs Directly to Tumor Site With Greater Efficacy, Reduced Side Effects
ICON, in one of the largest seed rounds for Texas start-ups in 2018, announces $9M in funding.
Rochester, MN | February 10, 2023 – Pneumeric Inc., developers of the Capnospot™ - A disposable medical device that allows visual detection of carbon dioxide during treatment of a collapsed lung with needle decompression, has raised nearly $40,000 from 124 investors through its recently launched equity crowdfunding campaign. These funds build on the $1.2 million Pneumeric has
/PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, today announced that it has closed more than $2.3M in its expanded...